Carcinoma of the penis.
Carcinoma of the penis. Arch Esp Urol. 2017 Apr;70(3):373-374 Authors: Menéndez López V, Hernández Pozo H, Urmeneta Sanroma JM, Díaz Cárdenas D, Castells Puñet H, Fernández Zuazu J PMID: 28422040 [PubMed - in process]
Publication date: January 2018 Source:Urology Case Reports, Volume 16 Author(s): Samira Pereira das Posses, Gotardo Zini Pinho, Gustavo Ruschi Bechara, Bruno Costa do Prado, Márcio Maia Lamy de Miranda
Abstract We examine trends in incidence, mortality and survival of penile squamous cell carcinoma (SCC) in Norway over 60 years. Data on all cases of penile cancer diagnosed in Norway during 1956‐2015 was obtained from the Cancer Registry of Norway. Trends in age‐standardised rates of penile SCC incidence, mortality and 5‐year relative survival were assessed by the annual percentage change statistic and joinpoint regression. A total of 1596 penile cancer cases were diagnosed during 1956‐2015, among which 1474 (92.4%) were SCC. During 2011‐2015, the age‐standardised incidence and mortality of penile SCC were 0.9...
ConclusionEarly stage penile carcinomas can be effectively treated with an organ preservation strategy. Tm:YAG conservative laser treatment is easy, safe and offers good functional outcome, with a minor impact on patient ’s quality of life.
Conclusion Brachytherapy is feasible in selected older patients with penile carcinoma, with efficacy and toxicity rates comparable to that of other series in younger patients.
This article is protected by copyright. All rights reserved.
Conclusion: Our results suggest that APOBEC3A expression is downregulated during progression towards invasiveness in HPV-negative penile SCC, but maintained in HPV-positive penile SCC. How high-risk HPV-infected tumor cells tolerate high APOBEC3A, which appears to exert tumor suppressive functions in HPV-negative penile SCCs, remains to be elucidated.Pathobiology
We thank “***”(editor please enter letter's lead author's last name) and colleagues for their comments regarding our evaluation of minimally-invasive inguinal lymphadenectomy.
To compare differences of morbidity profile, oncological yield&efficacy between video endoscopic inguinal lymphadenectomy and open inguinal lymphadenectomy cases.
Z. S. Li, K. Yao, Y. H. Li, J. P. Chen, C. Z. Deng, Q. Zhao, P. Chen, B. Wang, Q. W. Mi, Z. W. Liu, Z. K. Qin, H. Han and F. J. Zhou